A Cost-Effectiveness Analysis of Novel Oral Anticoagulants for Primary Prevention of Venous Thromboembolic Disease
Abstract
Authors
P Bryden NJ Welton H Thom J Sterne P Bodalia P Davies J López-López GN Okoli DM Caldwell S Dias D Eaton J Higgins C Salisbury J Savovic R Sofat A Stephens-Boal A Hingorani W Hollingworth